ASLAN Pharmaceuticals

Investor Relations

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
SC 13G

A statement of beneficial ownership of common stock by certain persons
Other
 View HTML
0001140361-23-012589.pdf
0001140361-23-012589.rtf
0001140361-23-012589.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0000950170-23-007135.pdf
0000950170-23-007135.rtf
0000950170-23-007135.xls
SC 13G

A statement of beneficial ownership of common stock by certain persons
Other
 View HTML
0000921895-23-000654.pdf
0000921895-23-000654.rtf
0000921895-23-000654.xls
F-6 POS

Post-effective amendment to a previously filed F-6
Registration Statements
 View HTML
0001193805-23-000272.pdf
0001193805-23-000272.rtf
0001193805-23-000272.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001193125-23-047981.pdf
0001193125-23-047981.rtf
0001193125-23-047981.xls
SC 13G/A

An amendment to the SC 13G filing
Other
 View HTML
0000902664-23-001739.pdf
0000902664-23-001739.rtf
0000902664-23-001739.xls
SC 13G/A

An amendment to the SC 13G filing
Other
 View HTML
0001214659-23-002391.pdf
0001214659-23-002391.rtf
0001214659-23-002391.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0000950170-23-001415.pdf
0000950170-23-001415.rtf
0000950170-23-001415.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0000950170-23-000085.pdf
0000950170-23-000085.rtf
0000950170-23-000085.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0000950170-22-026849.pdf
0000950170-22-026849.rtf
0000950170-22-026849.xls